Despite low p-S-STAT1 levels, virus infections in MS are half as frequent as in healthy controls and are most reduced in patients with high EDSS scores, based on studies predating widespread use of MS disease-modifying therapies [38–40]. The gene discussed is STAT1; the disease is myeloid sarcoma.